The determination of a panel of proinflammatory cytokines in serum samples from P10 outside clinical events (n = 2) and during mild COVID-19 (n = 1, 4 days from symptom onset) showed an increase in IL-6 levels during infection (Supplemental Figure 1A). The gene discussed is IL6; the disease is COVID-19.